Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient

In recent years, the detection rate of nontuberculous mycobacteria has increased, drawing attention in clinical settings. Here, we present a case of pulmonary Pseudomonas aeruginosa and Mycobacterium wolinskyi coinfection in a 60-year-old hemodialysis recipient. To the best of our knowledge, this is the first instance of isolating the M. wolinskyi strain from human respiratory samples, including a comprehensive exploration of its susceptibility to clinically available antimicrobials. This discovery deepened our understanding of the infection spectrum of M. wolinskyi, highlighting the need to consider the potential for coinfections with common pathogens and less common atypical pathogens when managing immunocompromised patients. Furthermore, this study also assessed the in vitro antibacterial activity of newly available antibacterial drugs in clinical practice against the M. wolinskyi strain.

Authors

Institutions

Publication Details

Journal
Journal of Global Antimicrobial Resistance
Published
2025-09-23
DOI
https://doi.org/10.1016/j.jgar.2025.09.006
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient

Yanwan Shangguan, Lin Zheng, Zhongkang Ji, Kaijin Xu et al.
Journal of Global Antimicrobial Resistance
Mycobacterium research and diagnosis
article

Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient

Yanwan Shangguan, Lin Zheng, Zhongkang Ji, Kaijin Xu, Wanru Guo
article en

Abstract

In recent years, the detection rate of nontuberculous mycobacteria has increased, drawing attention in clinical settings. Here, we present a case of pulmonary Pseudomonas aeruginosa and Mycobacterium wolinskyi coinfection in a 60-year-old hemodialysis recipient. To the best of our knowledge, this is the first instance of isolating the M. wolinskyi strain from human respiratory samples, including a comprehensive exploration of its susceptibility to clinically available antimicrobials. This discovery deepened our understanding of the infection spectrum of M. wolinskyi, highlighting the need to consider the potential for coinfections with common pathogens and less common atypical pathogens when managing immunocompromised patients. Furthermore, this study also assessed the in vitro antibacterial activity of newly available antibacterial drugs in clinical practice against the M. wolinskyi strain.

Journal of Global Antimicrobial ResistanceVol. 45
National Clinical Research Center for Digestive Diseases (CN), National Clinical Research (US), National Center for Infectious Diseases (US), First Affiliated Hospital Zhejiang University (CN), State Key Laboratory of Diagnosis and Treatment of Infectious Diseases, Zhejiang University (CN)
Openalex Percentile: Top 65%
Mycobacterium research and diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.